arrow
J

Jantana Yahuafai

National Cancer Institute
H指数:11
被引数:383

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Flavaglines as cross-kingdom translation inhibitors: Heavy halides at C6 potentiate antineoplastic, antiviral, and antifungal activities

黄酮类作为跨王国翻译抑制剂:C6位重卤素增强抗肿瘤、抗病毒和抗真菌活性

2026-10-070
PRE
Antimicrobial activity of the rationally modified peptide KK12 and its evaluation in a cooked chicken challenge model inoculated with Salmonella enterica serovar Typhimurium

理性修饰的多肽KK12的抗菌活性及其在接种鼠伤寒沙门氏菌的熟鸡肉挑战模型中的评估

2026-09-010
OAAI
Exploring new quinoxaline, quinoline, and naphthalene carboxamides as HDAC-targeted anticancer agents: Cytotoxicity, enzymatic HDAC evaluation, and in silico studies

探索新型喹喔啉、喹啉和萘甲酰胺作为HDAC靶向抗癌剂:细胞毒性、HDAC酶学评价和计算机模拟研究

2026-05-280
PRE
Phenoxy-Linked Colchicine Derivatives: A Structure-Based Approach toward Enhanced Selectivity and α-Tubulin Interaction

芳氧基连接的秋水仙碱衍生物:一种基于结构的增强选择性和微管蛋白α-亚基相互作用的方法

2026-03-030
PRE
Structural modifications of toxyloxanthone C and macluraxanthone isolated from Maclura cochinchinensis: cytotoxicity; antibacterial activity; and in silico studies

从Maclura cochinchinensis中分离得到的toxyloxanthone C和macluraxanthone的结构修饰:细胞毒性;抗菌活性;以及在体外的计算机模拟研究

2025-09-220
OA